Table: Mochida Pharm -2023/24 parent results
May 13 (Reuters)-
Mochida Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2024 Mar 31, 2023 Mar 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 94.24 95.49
(-1.3 pct) (-6.8 pct)
Operating 3.22 6.41
(-49.8 pct) (-43.6 pct)
Recurring 5.36 8.97
(-40.3 pct) (-33.7 pct)
Net 4.67 7.25
(-35.6 pct) (-30.6 pct)
EPS 130.27 yen 195.10 yen
Ann Div 80.00 yen 80.00 yen 80.00 yen
-Q2 Div 40.00 yen 40.00 yen 40.00 yen
-Q4 Div 40.00 yen 40.00 yen 40.00 yen
NOTE - Mochida Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T